This research develops a novel dermal filler that improves skin restoration and holds promise for tissue defects.
Current injectable fillers often suffer from a transient efficacy and insufficient early stage improvement. To address this, we developed a composite dermal filler consisting of hyaluronic acid (HA) and poly-L-lactic acid-methoxypolyethyleneglycol (PLLA-mPEG) microspheres with a unique fibrous porous structure. This distinctive architecture enabled a rapid initial release of lactic acid, effectively accelerating early cell proliferation and fundamentally overcoming the challenge of poor initial skin improvement. In a rat model, the composite filler demonstrated superior performance by orchestrating a pro-regenerative microenvironment, eliciting controlled macrophage infiltration, upregulating TGF-β expression, and significantly stimulating endogenous collagen regeneration, which leads to sustained volume restoration. By ingeniously coupling the instant filling effect of HA with the structurally enhanced bioactive function of PLLA-mPEG microspheres, this composite filler represents a breakthrough strategy that synchronizes immediate correction with long-term tissue remodeling, holding great promise for treating skin laxity and soft tissue defects.
No takes yet. Share an insight, caveat, or question.
Lian et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: